GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » EV-to-EBITDA

Kindstar Globalgene Technology (HKSE:09960) EV-to-EBITDA : -4.29 (As of Apr. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Kindstar Globalgene Technology EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Kindstar Globalgene Technology's enterprise value is HK$-404 Mil. Kindstar Globalgene Technology's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was HK$94 Mil. Therefore, Kindstar Globalgene Technology's EV-to-EBITDA for today is -4.29.

The historical rank and industry rank for Kindstar Globalgene Technology's EV-to-EBITDA or its related term are showing as below:

HKSE:09960' s EV-to-EBITDA Range Over the Past 10 Years
Min: -6.66   Med: -2.96   Max: 1.15
Current: -4.72

During the past 6 years, the highest EV-to-EBITDA of Kindstar Globalgene Technology was 1.15. The lowest was -6.66. And the median was -2.96.

HKSE:09960's EV-to-EBITDA is ranked better than
99.15% of 117 companies
in the Medical Diagnostics & Research industry
Industry Median: 16.18 vs HKSE:09960: -4.72

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-26), Kindstar Globalgene Technology's stock price is HK$1.60. Kindstar Globalgene Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was HK$0.047. Therefore, Kindstar Globalgene Technology's PE Ratio for today is 34.04.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Kindstar Globalgene Technology EV-to-EBITDA Historical Data

The historical data trend for Kindstar Globalgene Technology's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindstar Globalgene Technology EV-to-EBITDA Chart

Kindstar Globalgene Technology Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - - -1.50 4.14 -5.72

Kindstar Globalgene Technology Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.50 - 4.14 - -

Competitive Comparison of Kindstar Globalgene Technology's EV-to-EBITDA

For the Diagnostics & Research subindustry, Kindstar Globalgene Technology's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kindstar Globalgene Technology's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Kindstar Globalgene Technology's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Kindstar Globalgene Technology's EV-to-EBITDA falls into.



Kindstar Globalgene Technology EV-to-EBITDA Calculation

Kindstar Globalgene Technology's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=-404.185/94.183
=-4.29

Kindstar Globalgene Technology's current Enterprise Value is HK$-404 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kindstar Globalgene Technology's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was HK$94 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kindstar Globalgene Technology  (HKSE:09960) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Kindstar Globalgene Technology's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.60/0.047
=34.04

Kindstar Globalgene Technology's share price for today is HK$1.60.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Kindstar Globalgene Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was HK$0.047.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Kindstar Globalgene Technology EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Kindstar Globalgene Technology's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Kindstar Globalgene Technology (HKSE:09960) Business Description

Traded in Other Exchanges
N/A
Address
Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN
Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services. It organizes the business into nine segments, including hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, and Other segment provides Testing services for R&D projects and others and miscellaneous services.

Kindstar Globalgene Technology (HKSE:09960) Headlines

No Headlines